|AAV TEST BATCHES|
AAV for pilot experiments
The success of AAV in vivo experiments is, beside virus quality and titer, highly dependent on the best suitable serotype and promoter choice.
- scientific project consulting and planning (especially in ophthalmology and cardiology)
- ssAAV-CMV-GFP test batches with 1-2 X10E11GC delivered in 1-4 weeks for serotypes 1-6 & 1/2
- a broad functionality tested tissue specific promoter portfolio to enhance and optimize specificity. This includes heart, skeletal muscle, liver, CNS and retina.
- * Promoters can be used for custom AAV generation or are available as rAAV expression plasmids.
Find your best suitable serotype
The following table serves as a guideline for first AAV experiments and includes only the serotypes 1-6 which can be commercialized by SIRION. Recommendations are based on experimental data after systemic injection in mice as described in Zincarelli et al. 2008/ Molecular Therapy.
NEW: KeraAAV - keratinocyte specific AAV serotype
Please contact us for more information